The Headache Inducing Effects of Cilostazol on Migraine Patients

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

We will use Cilostazol as a tool to investigate its headache inducing effects in migraine patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Danish Headache Center
• Treatments: Cilostazol

Criteria

Inclusion Criteria:

• Diagnosed with migraine without aura according to the IHS criteria from 2004.

• Healthy besides migraine

Exclusion Criteria:

• Tension-type headache more than 3 days per month

• Other types of primary headaches

• Pregnancy

• History of vascular diseases or psychiatric diseases.